Sylvian Gabriel Goutebroze

Title: Sylvian Gabriel Goutebroze: Innovator in Veterinary Vaccines

Introduction

Sylvian Gabriel Goutebroze is a notable inventor based in Lyon, France. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for feline diseases. With a total of 2 patents, Goutebroze's work is crucial for improving animal health.

Latest Patents

Goutebroze's latest patents focus on inactivated vaccines against feline calicivirosis. These immunogenic preparations are designed to be effective against feline calicivirosis, utilizing an FCV virus strain 431, which has been deposited at the CNCM under the accession number CNCM I-2166. The vaccines are formulated in a veterinarily acceptable vehicle or excipient and are preferably combined with FCV virus obtained from another strain, specifically strain G1, which is also deposited at the CNCM under the accession number CNCM I-2167.

Career Highlights

Goutebroze is currently associated with Merial Limited, a company known for its commitment to animal health. His work at Merial has allowed him to focus on innovative solutions for veterinary challenges, particularly in vaccine development.

Collaborations

Goutebroze collaborates with Herve Poulet, a fellow professional in the field. Their partnership enhances the research and development efforts at Merial Limited, contributing to advancements in veterinary medicine.

Conclusion

Sylvian Gabriel Goutebroze is a key figure in the development of veterinary vaccines, with a focus on feline calicivirosis. His contributions through patents and collaboration with industry professionals underscore the importance of innovation in animal health.